Pleuropulmonary Disease in a Man with Diabetes Who Was Treated with Troglitazone
- 5 November 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (19) , 1400
- https://doi.org/10.1056/NEJM199811053391916
Abstract
Troglitazone is an antidiabetic drug that decreases hyperglycemia by increasing the sensitivity of peripheral tissue to insulin.1 Its most serious adverse effect is hepatic dysfunction, which occurs in a small percentage of patients.2 We describe a case of pleuritis in a patient who was treated with troglitazone.Keywords
This publication has 3 references indexed in Scilit:
- Hepatic Dysfunction Associated with TroglitazoneNew England Journal of Medicine, 1998
- A Novel Antidiabetic Drug, Troglitazone — Reason for Hope and ConcernNew England Journal of Medicine, 1998
- Drug-induced pulmonary diseaseDisease-a-Month, 1994